Antibodies are now established as therapeutics and indispensable in the research lab. In contrast to high-quality therapeutics, commercial antibodies used in research often do not properly function. Researchers demand that antibodies used in research should be made by recombinant DNA technology - just like therapeutic antibodies.
Researchers bioengineered the microstructures to be the same size, shape and stiffness as adult heart muscle cells, or cardiomyocytes, with the goal of releasing biologically active peptides that act as cardioprotective agents.
Lab-on-a-chip (LOC) systems have registered tremendous progress over the past 20 years. Myriad 'chip' schemes have already emerged, ranging from the lung-on-a-chip and heart-on-a-chip to the liver-on-a-chip and kidney-on-a-chip. However, until now, an ideal embryo-on-a-chip has not yet been developed due to challenges in condensing so many life factors inside a conventional LOC.
Researchers in Japan have succeeded in inducing human embryonic stem cells to self-organize into a three-dimensional structure similar to the cerebellum, providing tantalizing clues in the quest to recreate neural structures in the laboratory.
The scientific community represented by about forty researchers and officials from research funding organisations gathered in Brussels on 23 January 2015 to present the outcomes of the European Science Foundation's (ESF) Foresight Activity on Research in Quantum Biology (FarQBio).
Sites where DNA is damaged may cause a molecule that slides along the DNA strand to scan for damage to slow on its patrol, delaying it long enough to recognize and initiate repair. The finding suggests that the delay itself may be the key that allows the protein molecule to find its target, according to the researchers.